239 related articles for article (PubMed ID: 33850736)
21. A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma.
Xu Z; Xu L; Liu L; Li H; Jin J; Peng M; Huang Y; Xiao H; Li Y; Guan H
Front Oncol; 2021; 11():625452. PubMed ID: 33954109
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment.
Hu B; Zhang X; Zhu S; Wang C; Deng Z; Wang T; Wu Y
Eur J Med Res; 2024 Jan; 29(1):92. PubMed ID: 38297388
[TBL] [Abstract][Full Text] [Related]
23. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Liu GM; Zeng HD; Zhang CY; Xu JW
Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
[TBL] [Abstract][Full Text] [Related]
24. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
25. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.
Su Q; Liu Z; Chen C; Gao H; Zhu Y; Wang L; Pan M; Liu J; Yang X; Tian J
Cancer Med; 2021 Sep; 10(18):6492-6502. PubMed ID: 34453418
[TBL] [Abstract][Full Text] [Related]
26. A Novel Angiogenesis-Related Gene Signature to Predict Biochemical Recurrence of Patients with Prostate Cancer following Radical Therapy.
Fan B; Wang Y; Zheng X; Zhang X; Zhang Z; Hu X
J Oncol; 2022; 2022():2448428. PubMed ID: 35799610
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of novel inflammatory response-related gene signature to predict prostate cancer recurrence and response to immune checkpoint therapy.
Luo Y; Liu X; Lin J; Zhong W; Chen Q
Math Biosci Eng; 2022 Aug; 19(11):11345-11366. PubMed ID: 36124593
[TBL] [Abstract][Full Text] [Related]
28. A seven-gene prognosis model to predict biochemical recurrence for prostate cancer based on the TCGA database.
He Y; Zhang J; Chen Z; Sun K; Wu X; Wu J; Sheng L
Front Surg; 2022; 9():923473. PubMed ID: 37255653
[TBL] [Abstract][Full Text] [Related]
29. The Development of a Gleason Score-Related Gene Signature for Predicting the Prognosis of Prostate Cancer.
Yimamu Y; Yang X; Chen J; Luo C; Xiao W; Guan H; Wang D
J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498737
[TBL] [Abstract][Full Text] [Related]
30. A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer.
Shao N; Tang H; Mi Y; Zhu Y; Wan F; Ye D
Oncoimmunology; 2020 Jun; 9(1):1762473. PubMed ID: 32923125
[TBL] [Abstract][Full Text] [Related]
31. A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy.
Shi R; Bao X; Weischenfeldt J; Schaefer C; Rogowski P; Schmidt-Hegemann NS; Unger K; Lauber K; Wang X; Buchner A; Stief C; Schlomm T; Belka C; Li M
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861273
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
33. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Zhang Q; Hong J
Front Genet; 2020; 11():363. PubMed ID: 32351547
[TBL] [Abstract][Full Text] [Related]
34. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
[TBL] [Abstract][Full Text] [Related]
35. Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer.
Yu Z; Chao H; Xu F; Deng H; Deng L; Song Z; Zeng T
Front Oncol; 2023; 13():1115718. PubMed ID: 37077837
[TBL] [Abstract][Full Text] [Related]
36. An anoikis-related gene signature for prediction of the prognosis in prostate cancer.
Zhao X; Wang Z; Tang Z; Hu J; Zhou Y; Ge J; Dong J; Xu S
Front Oncol; 2023; 13():1169425. PubMed ID: 37664042
[TBL] [Abstract][Full Text] [Related]
37. Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery.
Li F; Ji JP; Xu Y; Liu RL
Clin Transl Oncol; 2019 Aug; 21(8):1067-1075. PubMed ID: 30637711
[TBL] [Abstract][Full Text] [Related]
38. A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy.
Li X; Huang H; Zhang J; Jiang F; Guo Y; Shi Y; Guo Z; Ao L
Prostate; 2020 Apr; 80(5):376-387. PubMed ID: 31961962
[TBL] [Abstract][Full Text] [Related]
39. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
40. Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer.
Liu B; Li X; Li J; Jin H; Jia H; Ge X
Dis Markers; 2020; 2020():8860788. PubMed ID: 33101546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
